Intriguingly, prostatic cancer patients with low level of HMGCR (http://gepia.cancer-pku.cn/) and ovarian cancer patients with high level of HMGCR (http://kmplot.com/analysis/) represented higher overall survival rate (Figure 6M,N). This evidence concerns the gene HMGCR and prostate cancer.